Evaluation of the Corneal Endothelial Cell Layer by Specular Microscopy in Patients With Thyroid Eye Disease
1 other identifier
observational
30
0 countries
N/A
Brief Summary
To investigate corneal endothelial cell layer damage by specular microscopy in patients with thyroid eye disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2023
CompletedFirst Posted
Study publicly available on registry
January 31, 2024
CompletedStudy Start
First participant enrolled
March 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2025
CompletedMarch 20, 2024
January 1, 2024
1.6 years
December 22, 2023
March 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Damage of the corneal endothelial cells in patients with thyroid eye disease by specular microscopy
To detect if there is any change in corneal endothelial cell layer in patients with thyroid eye disease
Baseline
Interventions
Specular microscopy is a noninvasive photographic technique that analyze the corneal endothelium. Using computer-assisted morphometry, modern specular microscopes analyze the size, shape and population of the endothelial cells. The instrument projects light onto the cornea and captures the image that is reflected from the optical interface between the corneal endothelium and the aqueous humor. The reflected image is analyzed by the instrument and displayed as a specular photomicrograph .
Eligibility Criteria
Patients with thyroid eye disease whom diagnosis was established based on bartley diagnostic criteria .
You may qualify if:
- Patients with thyroid eye disease whom diagnosis was established based on bartley diagnostic criteria .
You may not qualify if:
- participates with systemic diseases other than HT such as
- diabetes mellitus
- previous ocular surgery or laser therapy.
- history of corneal disease.
- history of trauma.
- history of glaucoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dalia Mohammed, Professor
Academic organizations
- STUDY DIRECTOR
Khaled Abdelazim, Assistant professor
Academic organizations
- STUDY DIRECTOR
Ahmed Abdelnasser, Lecturer
Academic organizations
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 22, 2023
First Posted
January 31, 2024
Study Start
March 21, 2024
Primary Completion
October 22, 2025
Study Completion
December 22, 2025
Last Updated
March 20, 2024
Record last verified: 2024-01